• Andrew Cheng to quit Gilead 6 months after taking CMO post fiercebiotech
    August 16, 2018
    Andrew Cheng, M.D., Ph.D., is set to leave Gilead six months after being appointed CMO. Cheng’s swift exit keeps the revolving door spinning at the top of Gilead, which is set to lose its CEO, CMO, CSO and executive chairman over a nine-month window.
PharmaSources Customer Service